Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and Other Liabilities (Details)

v3.21.2
Accrued expenses and Other Liabilities (Details) - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Accrued Expenses and Other Liabilities    
Accrued clinical trial expenses $ 873,042 $ 628,000
Accrued manufacturing expenses 167,915 175,089
Compensation and related benefits 190,053 209,600
Accrued franchise tax 100,000 172,500
Other expenses 435,301 429,345
Accrued expenses $ 1,766,311 $ 1,614,534